These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Outcomes for off-pump coronary artery bypass grafting in high-risk groups: a historical perspective.
    Author: Moore GJ, Pfister A, Trachiotis GD.
    Journal: Heart Surg Forum; 2005; 8(1):E19-22. PubMed ID: 15769707.
    Abstract:
    BACKGROUND: The outcomes of off-pump coronary artery bypass (OPCAB) and conventional coronary artery bypass grafting with cardiopulmonary bypass (cCABG) have been compared in detail. Similarly, several reports have examined outcomes of high-risk subsets of patients in OPCAB as a selection strategy for reducing morbidity and mortality compared to cCABG. We undertook a retrospective study comparing outcomes from the early years in our experience of beating-heart surgery in high-risk patients selected for OPCAB compared to low-risk patients having OPCAB. This study was premised on strict selection criteria in an era prior to stabilizing devices and cardiac positioners. METHODS: A total of 384 patients underwent OPCAB over a 10-year period. Clinical outcomes were compared for 280 low-risk patients and 104 high-risk patients (redo CABG, CABG with simultaneous carotid endarterectomy, or renal insufficiency/failure). RESULTS: The high-risk group patients were significantly older than the low-risk group patients (64.3 +/- 10.5 years versus 61.5 +/- 11.7 years, respectively, P = .048). The high-risk group also had a greater degree of left ventricular dysfunction (P < .001), a higher incidence of diabetes (P = .046), and a higher proportion of patients with peripheral vascular disease (P = .009). There was no significant difference in the number of grafts created, but there was a statistical difference in the type of graft used. The high-risk group received fewer internal thoracic artery grafts (P = .005) and more saphenous vein grafts (P = .041). The high-risk group had slightly prolonged median lengths of stay in the intensive care unit (2.2 versus 1.4 days, P < .001) and hospital (11 versus 8 days, P < .001) and a higher proportion of patients requiring blood transfusions (48% versus 24%, P < .001), yet there was no significant difference in major adverse outcomes. CONCLUSIONS: In this retrospective and historical review, OPCAB was found to be equally safe in carefully selected high- and low-risk patients. These results provided for the enthusiasm and innovation to expand the usage of OPCAB in patients with coronary artery disease.
    [Abstract] [Full Text] [Related] [New Search]